2,197
Views
47
CrossRef citations to date
0
Altmetric
Research Article

Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting

, , &
Pages 1328-1339 | Received 22 Mar 2018, Accepted 14 May 2018, Published online: 05 Jun 2018

References

  • Abdelrahman FE, Elsayed I, Gad MK, et al. (2015). Investigating the cubosomal ability for transnasal brain targeting: in vitro optimization, ex vivo permeation and in vivo biodistribution. Int J Pharm 490:281–91.
  • Aboud HM, Ali AA, El-Menshawe SF, Elbary AA. (2016). Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation. Drug Deliv 23:2471–81.
  • Ahmad A, Alkharfy KM, Wani TA, Raish M. (2015). Application of Box-Behnken design for ultrasonic-assisted extraction of polysaccharides from Ppaeonia emodi. Int J Biol Macromol 72:990–7.
  • Alexander NJ, Baker E, Kaptein M, et al. (2004). Why consider vaginal drug administration? Fertil Steril 82:1–12.
  • Almgrem M, Edwards K, Karlsson G. (2000). Cryo transmission electron microscopy of liposomes and related structures. Colloid Surface A 174:3–21.
  • Amit A, Thaler I, Paz Y, Itskovitz-Eldor J. (1998). The effect of a nitric oxide donor on Doppler flow velocity waveforms in the uterine artery during the first trimester of pregnancy. Ultrasound Obstet Gynecol 11:94–8.
  • Annadurai G, Ling LY, Lee JF. (2008). Statistical optimization of medium components and growth conditions by response surface methodology to enhance phenol degradation by Pseudomonas putida. J Hazard Mater 151:171–8.
  • Badawi MA, El-Khordagui LK. (2014). A quality by design approach to optimization of emulsions for electrospinning using factorial and D-optimal designs. Eur J Pharm Sci 58:44–54.
  • Bancroft JD, Gamble M. (2008). The hematoxyline and eosin. In: Suvaran K, LCaB JDCL, eds. Theory and practice of histological techniques. 6th ed. London: Elsevier Health Sciences, 121–34.
  • Baras B, Benoit MA, Gillard J. (2000). Parameters influencing the antigen release from spray-dried poly(DL-lactide) microparticles. Int J Pharm 200:133–45.
  • Bertram U, Bodmeier R. (2006). In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form. Eur J Pharm Sci 27:62–71.
  • Boskey ER, Cone RA, Whaley KJ, Moench TR. (2001). Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod 16:1809–13.
  • Cho HJ, Park JW, Yoon IS, Kim DD. (2014). Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. Int J Nanomed 9:495–504.
  • Cicinelli E, Cignarelli M, Sabatelli S, et al. (1998). Plasma concentrations of progesterone are higher in the uterine artery than in the radial artery after vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women. Fertil Steril 69:471–3.
  • de Lima LS, Araujo MD, Quináia SP, et al. (2011). Adsorption modeling of Cr, Cd and Cu on activated carbon of different origins by using fractional factorial design. Chem Eng J 166:881–9.
  • Değim IT, Tuğcu-Demiröz F, Tamer-Ilbasmis S, Acartürk F. (2008). Development of controlled release sildenafil formulations for vaginal administration. Drug Deliv 15:259–65.
  • Dehghani Firouzabadi R, Davar R, Hojjat F, Mahdavi M. (2013). Effect of sildenafil citrate on endometrial preparation and outcome of frozen-thawed embryo transfer cycles: a randomized clinical trial. Iran J Reprod Med 11:151–8.
  • De Ziegler D, Bulletti C, De Monstier B, Jaaskelainen AS. (1997). The first uterine pass effect. Ann N Y Acad Sci 828:291–9.
  • El-Far M, El-Motwally Ael G, Hashem IA, Bakry N. (2009). Biochemical role of intravaginal sildenafil citrate as a novel antiabortive agent in unexplained recurrent spontaneous miscarriage: first clinical study of four case reports from Egypt. Clin Chem Lab Med 47:1433–8.
  • Elgindy NA, Mehanna MM, Mohyeldin SM. (2016). Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery. Int J Pharm 501:167–79.
  • El-Nabarawi MA, Ali AA, Aboud HM, et al. (2016). Transbuccal delivery of betahistine dihydrochloride from mucoadhesive tablets with a unidirectional drug flow: in vitro, ex vivo and in vivo evaluation. Drug Des Devel Ther 10:4031–45.
  • Esposito E, Eblovi N, Rasi S, et al. (2003). Lipid-based supramolecular systems for topical application: a preformulatory study. AAPS PharmSci 5:E30.
  • Gabr MM, Mortada SM, Sallam MA. (2017). Hexagonal liquid crystalline nanodispersions proven superiority for enhanced oral delivery of rosuvastatin: in vitro characterization and in vivo pharmacokinetic study. J Pharm Sci 106:3103–12.
  • Ganem-Quintanar A, Quintanar-Guerrero D, Buri P. (2000). Monoolein: a review of the pharmaceutical applications. Drug Dev Ind Pharm 26:809–20.
  • Garti N, Libster D, Aserin A. (2012). Lipid polymorphism in lyotropic liquid crystals for triggered release of bioactives. Food Funct 3:700–13.
  • Gautam A, Singh GP, Ram S. (2007). Simple polyol synthesis of silver metal nanopowder of uniform particles. Synth Met 157:5–10.
  • Gomaa E, Abu Lila AS, Hasan AA, Ghazy FS. (2018). Preparation and characterization of intravaginal vardenafil suppositories targeting a complementary treatment to boost in vitro fertilization process. Eur J Pharm Sci 111:113–20.
  • Gonen Y, Casper RF. (1990). Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF). J Vitro Fert Embryo Transf 7:146–52.
  • Guo C, Wang J, Cao F, et al. (2010). Lyotropic liquid crystal systems in drug delivery. Drug Discov Today 15:1032–40.
  • Jerzak M, Kniotek M, Mrozek J, et al. (2008). Sildenafil citrate decreased natural killer cell activity and enhanced chance of successful pregnancy in women with a history of recurrent miscarriage. Fertil Steril 90:1848–53.
  • Kulkarni CV, Vishwapathi VK, Quarshie A, et al. (2017). Self-assembled lipid cubic phase and cubosomes for the delivery of aspirin as a model drug. Langmuir 33:9907–15.
  • Li JC, Zhu N, Zhu JX, et al. (2015). Self-assembled cubic liquid crystalline nanoparticles for transdermal delivery of paeonol. Med Sci Monit 21:3298–310.
  • Mahmoud MO, Aboud HM, Hassan AH, et al. (2017). Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats. J Control Release 254:10–22.
  • Milak S, Zimmer A. (2015). Glycerol monooleate liquid crystalline phases used in drug delivery systems. Int J Pharm 478:569–87.
  • Morsi NM, Abdelbary GA, Ahmed MA. (2014). Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and In vitro/In vivo characterization. Eur J Pharm Biopharm 86:178–89.
  • Nakano M, Sugita A, Matsuoka H, Handa T. (2001). Small angle x-ray scattering and 13C NMR investigation on the internal structure of “cubosomes.” Langmuir 17:3917–22.
  • Nasr M, Ghorab MK, Abdelazem A. (2015). In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting. Acta Pharm Sin B 5:79–88.
  • Patil S, Babbar A, Mathur R, et al. (2010). Mucoadhesive chitosan microspheres of carvedilol for nasal administration. J Drug Target 18:321–31.
  • Refai H, Hassan D, Abdelmonem R. (2017). Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate. Drug Deliv 24:278–88.
  • Rizwan SB, Assmus D, Boehnke A, et al. (2011). Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. Eur J Pharm Biopharm 79:15–22.
  • Rosen MR. (2005). Delivery system handbook for personal care and cosmetic products: technology, applications, and formulations. Norwich (NY): William Andrew Pub.
  • Shamma RN, Aburahma MH. (2014). Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia. Int J Nanomedicine 9:5449–60.
  • Shanmugam S, Kim YH, Park JH, et al. (2014). Sildenafil vaginal suppositories: preparation, characterization, in vitro and in vivo evaluation. Drug Dev Ind Pharm 40:803–12.
  • Sher G, Fisch JD. (2000). Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Hum Reprod 15:806–9.
  • Sher G, Fisch JD. (2002). Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertil Steril 78:1073–6.
  • Sher G, Herbert C, Maassarani G, Jacobs MH. (1991). Assessment of the late proliferative phase endometrium by ultrasonography in patients undergoing in-vitro fertilization and embryo transfer (IVF/ET). Hum Reprod 6:232–7.
  • Shi X, Peng T, Huang Y, et al. (2017). Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo. Pharm Dev Technol 22:322–9.
  • Siekmann B, Bunjes H, Koch MHJ, Westesen K. (2002). Preparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride–water phases. Int J Pharm 244:33–43.
  • Soliman GM, Fetih G, Abbas AM. (2017). Thermosensitive bioadhesive gels for the vaginal delivery of sildenafil citrate: in vitro characterization and clinical evaluation in women using clomiphene citrate for induction of ovulation. Drug Dev Ind Pharm 43:399–408.
  • Takasaki A, Tamura H, Miwa I, et al. (2010). Endometrial growth and uterine blood flow: a pilot study for improving endometrial thickness in the patients with a thin endometrium. Fertil Steril 93:1851–8.
  • Taurin S, Almomen AA, Pollak T, et al. (2017). Thermosensitive hydrogels a versatile concept adapted to vaginal drug delivery. J Drug Target. 1–18.
  • Tripathi AS, Sheikh I, Dewani AP, et al. (2013). Development and validation of RP-HPLC method for sildenafil citrate in rat plasma-application to pharmacokinetic studies. Saudi Pharm J 21:317–21.
  • Valenta C. (2005). The use of mucoadhesive polymers in vaginal delivery. Adv Drug Deliv Rev 57:1692–712.
  • Villanueva-García D, Mota-Rojas D, Hernández-González R, et al. (2007). A systematic review of experimental and clinical studies of sildenafil citrate for intrauterine growth restriction and pre-term labour. J Obstet Gynaecol 27:255–9.
  • Wang Y, Chow MS, Zuo Z. (2008). Mechanistic analysis of pH dependent solubility and trans-membrane permeability of amphoteric compounds: application to sildenafil. Int J Pharm 352:217–24.
  • Weckstein LN, Jacobson A, Galen D, et al. (1997). Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. Fertil Steril 68:927–30.
  • Werner U, Damge C, Maincent P, Bodmeier R. (2004). Properties of in situ gelling nasal insert containing estradiol/methyl β-cyclodextrin. J Drug Deliv Sci Tech 14:275–84.
  • Woolfson AD, Malcolm RK, Gallagher R. (2000). Drug delivery by the intravaginal route. Crit Rev Ther Drug Carrier Syst 17:509–55.
  • Yang D, Armitage B, Marder SR. (2004). Cubic liquid-crystalline nanoparticles. Angew Chem Int Ed Engl 43:4402–9.
  • Zhao XY, Zhang J, Zheng LQ, Li DH. (2004). Studies of cubosomes as a sustained drug delivery system. J Disp Sci Technol 25:795–9.
  • Zinger M, Liu JH, Thomas MA. (2006). Successful use of vaginal sildenafil citrate in two infertility patients with Asherman’s syndrome. J Womens Health 15:442–4. (Larchmt)